Patents by Inventor Debashis Mitra

Debashis Mitra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210196718
    Abstract: The present invention relates to compounds and pharmaceutical composition having antiviral effects. Over 1200 molecules were screened and 55 molecules having statistically significant anti-HIV activity were identified and selected. The compound Methotrexate (MTX-HYD) and its analogues, the combinations thereof and their combination with other anti-retrovirals were selected for repurposing the compounds as anti-HIV drugs. The present invention may further relate to pharmaceutical composition comprising compounds in combination with active drugs having anti-HIV activity.
    Type: Application
    Filed: May 10, 2019
    Publication date: July 1, 2021
    Applicant: NATIONAL CENTRE FOR CELL SCIENCE
    Inventors: Debashis MITRA, Jay TRIVEDI
  • Patent number: 8729034
    Abstract: Acaciaside-B (Ac-B) has emerged as a prospective candidate molecule for prevention of HIV infection along with potential for use as/in vaginal contraceptive/formulation. It possesses anti-HIV property at a tolerably low concentration, is non-mutagenic and does not harm the niche of Lactobacilli. Thus Ac-B appears to be a superior ingredient for formulations of a chemical barrier against HIV-1 infection wherein its spermicidal property is superfluous.
    Type: Grant
    Filed: May 27, 2008
    Date of Patent: May 20, 2014
    Assignee: Council of Scientific and Industrial Research
    Inventors: Syed Nazrul Kabir, Heramba Nanda Ray, Bikash C. Pal, Debashis Mitra
  • Publication number: 20080300197
    Abstract: Acaciaside-B (Ac-B) has emerged as a prospective candidate molecule for prevention of HIV infection along with potential for use as/in vaginal contraceptive/formulation. It possesses anti-HIV property at a tolerably low concentration, is non-mutagenic and does not harm the niche of Lactobacilli. Thus Ac-B appears to be a superior ingredient for formulations of a chemical barrier against HIV-1 infection wherein its spermicidal property is superfluous.
    Type: Application
    Filed: May 27, 2008
    Publication date: December 4, 2008
    Inventors: Syed Nazrul Kabir, Heramba Nanda Ray, Bikash C. Pal, Debashis Mitra